SSX2 and prostate cancer: Interestingly, SSX2 mRNA expression was increased by treatment with demethylating agent 5-aza-2′deoxycytidine (AZA) in the prostate cancer cell lines LNCAP and DU145 but not in the normal prostate epithelial cell line RWPE-1 [10].